menu search

Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition

– Both Mitapivat Dose Arms Achieved statistically Significant Hemoglobin Response in Phase 2 Portion ...

November 2, 2023, 9:05 am

Park hotels & resorts inc. reports third quarter 2023 results and announces special dividend of $0.77 per share

TYSONS, Va., Nov. 01, 2023 (GLOBE NEWSWIRE) — Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE: PK) today announced results for th...

November 1, 2023, 8:15 pm

European economic news preview: eurozone flash gdp, inflation due

Inflation and quarterly national accounts from the euro area are the top economic news due on Tuesday, headlining a hectic day for the European econom...

October 31, 2023, 4:35 am

Bankfinancial corporation reports financial results for the third quarter 2023 and will host conference call and webcast on wednesday, november 1, 2023

BURR RIDGE, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) — BankFinancial Corporation (Nasdaq – BFIN) (the “BankFinancial”) filed its Quarterly Report ...

October 30, 2023, 8:37 pm

Bankfinancial corporation reports financial results for the third quarter 2023 and will host conference call and webcast on wednesday, november 1, 2023

BURR RIDGE, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) -- BankFinancial Corporation (Nasdaq – BFIN) (the “BankFinancial”) filed its Quarterly Report...

October 30, 2023, 4:37 pm

Sarepta's gene therapy fails to meet primary goal in rare muscular dystrophy trial

Sarepta Therapeutics' gene therapy to treat Duchenne muscular dystrophy failed to reach statistical sig...

October 30, 2023, 4:11 pm

European economic news preview: france consumer confidence data due

Consumer sentiment survey data from France and business confidence from Italy are the major economic data due on Friday. At 2.00 am ET, retail sales f...

October 27, 2023, 5:17 am

European economic news preview: germany ifo business confidence data due

Business sentiment survey data from Germany and monetary aggregates from the euro area are the top economic news due on Wednesday. At 3.00 am ET, Spai...

October 25, 2023, 4:49 am

: merck’s keytruda shows positive results in confirmatory trial as treatment for rare form of esophageal cancer

Merck & Co. MRK said Friday a late-stage trial of its blockbuster cancer drug Keytruda plus trastuzumab, fluoropyrimidine- and platinum-containing che...

October 20, 2023, 12:13 pm

Merck's keytruda shows positive results in confirmatory trial as treatment for rare form of esophageal cancer

Merck & Co. MRK, -1.53% said Friday a late-stage trial of its blockbuster cancer drug Keytruda plus trastuzumab, fluoropyrimidine- and platinum-contai...

October 20, 2023, 8:13 am

Us equities bleed again, breaking yesterday's lows

Cue the sad trumpet noises...The early gains in US equities are gone and they're now trading at the lows of the day, even with US yields well off the ...

October 19, 2023, 3:26 pm

Investors add foreign equities in august: statscan

The national statistical agency reported that Canadian investors added $14.9 billion worth of foreign s...

October 17, 2023, 8:44 pm

Canada: business and consumer sentiment measures weaken in q3

According to the Bank of Canada Business Outlook Survey (BOS) Canadian business sentiment continued deteriorating in the third quarter of 2023. The BO...

October 17, 2023, 12:40 am

A number of risk advisory investigation firms are closing hong kong offices

The Wall Street Journal (gated) with the report. The closures come after US firm Mintz was raided earlier the year and staff detained. US firm Minz Gr...

October 16, 2023, 3:32 am

Akero (akro) slumps 63% on mixed results from nash study

Data from a mid-stage study shows that Akero Therapeutics' (AKRO) lead candidate failed to achieve statistical...

October 11, 2023, 12:47 pm

Why akero therapeutics stock is crashing today

Akero's experimental NASH drug efruxifermin (EFX) missed its primary endpoint in a phase 2b study. However, st...

October 10, 2023, 11:44 am

Merck immunotherapy shows further promise in lung cancer

Merck & Co confirmed that its cancer drug Keytruda has successfully met the second of its two primary targets in a phase III clinical trial,  showi...

October 10, 2023, 9:11 am

Akero's drug for fatty liver disease misses main trial goal

Akero Therapeutics said on Tuesday a mid-stage trial for its drug to treat a type of fatty liver disease showed improvement in patients, but the resul...

October 10, 2023, 7:33 am

Anavex: the september data

Anavex Life Sciences Corp. presented follow-on data from its Alzheimer's disease trial. This data uses a stati...

October 9, 2023, 11:37 am

Euro/dollar awaits economic figures: overview for october 06, 2023

EUR/USD is currently in a consolidation phase, eagerly anticipating vital statistical updates from the ...

October 6, 2023, 9:36 am


Search within

Pages Search Results: